No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 142 participants.

Also called NCT02128191

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 142 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02128191
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02128191. Randomized; quadruple masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2019-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
Condition
Bronchopulmonary Dysplasia (BPD)
Intervention (Drug)
Oral ibuprofen
Intervention (Drug)
Normal saline
Lead sponsor
Samsung Medical Center (class: other)

Record details

Record id
cardio:ct-nct02128191
Content hash
1326bfb7f5c88dee4c2167cbecb2d8b984cb5b5e8814d929089d0ea5e7d767cc